题名

Herbal Treatment for Osteoporosis: A Current Review

DOI

10.4103/2225-4110.110407

作者

Ping-Chung Leung;Wing-Sum Siu

关键词

Bone mineral density ; Herbal treatment ; Osteoporosis

期刊名称

Journal of Traditional and Complementary Medicine

卷期/出版年月

3卷2期(2013 / 04 / 01)

页次

82 - 87

内容语文

英文

中文摘要

Osteoporosis is an aging problem. The declining bone mineral density (BMD) enhances the chances of fractures during minor falls. Effective pharmaceuticals are available for a rapid improvement of BMD. However, hormonal treatment gives serious complications, and bisphosphonates may lead to odd fractures of long bones, resulting from excessive rigidity of the cortical components. Many medicinal herbs used in Traditional Chinese Medicine, known as kidney tonics, have been tested for their effects on bone metabolism in the laboratory and clinically. Three of these, viz. Herba epimedii (淫羊藿, Yín Yáng Huò), Fructus ligustri lucidi (女貞子, Nǚ Zhēn Zi), and Fructus psoraleae (補骨脂, Bǔ Gǔ Zhī) were chosen to form a herbal formula, ELP. ELP was tested on in vitro platforms and was shown to have both osteoblastic and anti-osteoclastic action. ELP tested on ovariectomized rats also showed BMD protection. ELP was then put on a placebo-controlled randomized clinical trial. BMD protection was obvious among those women with the onset of menopause beyond 10 years (P < 0.05). A general protective trend was observed among all women under trial (P > 0.05). Although a thorough literature review on the herbal treatment effects did not give convincing answers to the use of Chinese herbs in osteoporosis, our study supports more research and trials in this area, while we are looking for safe and effective agents to keep the bone metabolism in a balanced state.

主题分类 醫藥衛生 > 中醫藥學
参考文献
  1. Cai, L,Li, H,Wei, Y(1998).Effect of Yang Xue Bu Shen tablets on ovarian function in animal model of Yang deficiency.Chin J Integr Tradit West Med,18,620-622.
  2. Cai, L,Li, H,Wei, Y(1998).Effect of Yang‑Xue Bu‑Shen tablet on ovarian function in animal model of Yang‑deficiency.Chin J Integr Tradit West Med,18,620-622.
  3. Christiansen, C(1993).Prevention and treatment of osteoporosis with hormone replacement therapy.Int J Fertil Menopausal Stud,38(Suppl 1),45-54.
  4. Cummings, SR,Nevitt, MC,Browner, WS,Stone, K,Fox, KM,Ensrud, KE(1995).Risk factors for hip fracture in white women. Study of osteoporotic fractures research group.N Engl J Med,332,767-773.
  5. Dambacher, MA,Schmitt, S,Schacht, E,Ito, M,Neff, M,Muller, R(2004).Bone structures in vitro and in vivo in animals and men: A view into the future.J Miner Stoffwechsel,2,22-28.
  6. Fanti, P,Monier‑Faugere, MC,Geng, Z,Schmidt, J,Morris, PE,Cohen, D(1998).The phytoestrogen genistein reduces bone loss in short‑term ovariectomized rats.Osteoporos Int,8,274-281.
  7. Huang, HF,You, JS(1997).The use of Chinese herbal medicine on experimental fracture healing.Am J Chin Med,25,351-356.
  8. Ishida, H,Uesugi, T,Hirai, K,Toda, T,Nukaya, H,Yokotsuka, K(1998).Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium‑deficient diet.Biol Pharm Bull,21,62-66.
  9. Kwek, EB,Koh, JS,Howe, TS(2008).More on atypical fractures of the femoral diaphysis.N Engl J Med,359,316-317.
  10. Lau, EM(ed.),Ho, SC(ed.),Leung, S(ed.),Woo, J(ed.)(1997).Osteoporosis in Asia: Crossing the frontiers.Singapore:World Scientific.
  11. Leung, PC,Ko, EC,Siu, WS(2012).Developing an effective health supplement for the prevention of Osteoporosis.Int J Osteoporosis Metab Disord,5,1-12.
  12. Leung, PC,Ko, EC,Siu, WS(2011).Developing an effective food supplement for the prevention of osteoporosis functional foods.Health Dis,9,379-388.
  13. Li, NH,Ou, PZ,Zhu, HM,Yang, DZ,Zheng, PR,Liao, EY(2002).Epidemiological study on osteoporosis in middle‑aged and elderly population in China.Chin J Clin Rehabil,6,758-759.
  14. Lindsay, R,Hart, DM,Aitken, JM,MacDonald, EB,Anderson, JB,Clarke, AC(1976).Long‑term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delay onset of oestrogen treatment.Lancet,1,1038-1041.
  15. National Institutes of Health, US. NIH Consensus Statement of Osteoporosis prevention, diagnosis and therapy. Available from: http://Consensus.nih.gov. [Last accessed on 2000 Mar].
  16. Nelson, HD,Humphrey, LL,Nygren, P,Teutsch, SM,Allan, JD(2002).Postmenopausal hormone replacement therapy: Scientific review.JAMA,88,872-881.
  17. Neviaser, AS,Lane, JM,Lorich, DG(2008).Bisphosphonates and odd fractures.J Orth Trauma,22,346-348.
  18. Qin, L,Zhang, G,Hung, WY,Shi, Y,Leung, K,Yeung, HY(2005).Phytoestrogen rich herb formula "XLGB" prevent ovx‑induced deterioration of musculoskeletal tissues.J Bone Miner Metab,23(Suppl),55-61.
  19. Riggs, BL,Melton, LJ, 3rd(1995).The worldwide problem of osteoporosis: Insights efforded by epidemiology.Bone,17(5 Suppl),S505-S511.
  20. Setchell, KD,Lydeking‑Olsen, E(2003).Dietary phytoestrogens and their effect on bone: Evidence from in vitro and in vivo, human observational, and dietary intervention studies.Am J Clin Nutr,78(3 Suppl),593S-609S.
  21. Xie, F,Wu, CF,Lai, WP,Yang, XJ,Cheung, PY,Yao, XS(2005).The osteoprotective effect of Herba epimedii (HEP) extract in vivo and in vitro.Evid Based Complement Alternat Med,2,353-361.
  22. Xu, M,Qi, C,Deng, B,Deng, PX,Mo, CW(2009).Phytotherapy versus hormonal therapy for postmenopausal bone loss: A meta‑analysis.Osteoporos Int,20,519-526.
  23. Xu, M,Zhang, XH,Liu, SX(2002).Phytoestrogens in herbal medicine.Chin Drug Res Clin Pharmacol,13,261-263.
  24. Zhang, Y,Lai, WP,Wong, MS(2006).Effects of Fracutus Ligustri lucidi extract on bone turn over and calcium balsnce in ovariectomized rats.Biot Pharm Bull,29,291-296.
被引用次数
  1. (2024).Plant-derived natural medicines for the management of osteoporosis: A comprehensive review of clinical trials.Journal of Traditional and Complementary Medicine,14(1),1-18.